SCHEDULE: Raymond James Discloses 10.1% Stake in Highland Global Allocation Fund

Raymond James & Associates has reported beneficial ownership of 2,353,160.53 common shares, representing 10.1% of the class, in the Highland Global Allocation Fund as of March 31, 2026.

Summary

• Raymond James & Associates has filed a Schedule 13G, indicating their beneficial ownership of common shares in the Highland Global Allocation Fund.
• As of March 31, 2026, the firm beneficially owns 2,353,160.53 shares.
• This holding represents 10.1% of the total class of securities.
• Raymond James & Associates has sole power to dispose of these shares.
• The filing certifies that these securities were acquired and are held in the ordinary course of business and not for the purpose of influencing control of the issuer.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing. It's a standard disclosure of a significant investment stake, providing factual information about ownership without indicating positive or negative performance or future intentions beyond routine business operations.

Positives

• Raymond James & Associates, a significant financial institution, has taken a substantial stake (10.1%) in the Highland Global Allocation Fund, which could signal confidence in the fund's strategy or future performance.
• The filing confirms that the shares are held in the ordinary course of business, suggesting a standard investment activity rather than a hostile takeover attempt.

Negatives

• The filing does not provide specific financial performance data for the Highland Global Allocation Fund itself, only the ownership stake by Raymond James.

Risks

• While not explicitly stated as a risk in this filing, a significant ownership stake by an external entity like Raymond James could potentially lead to future changes in fund management or strategy, which may or may not be beneficial to existing investors.
• Market volatility could impact the value of the shares held by Raymond James & Associates.

Future Outlook

This filing is primarily a disclosure of current ownership and does not contain forward-looking statements or guidance regarding the future performance of the Highland Global Allocation Fund or Raymond James & Associates' future investment plans.

Management Comments

• "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under 240.14a-11."
• "After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct."

Industry Context

StockSavvy.ai notes that Schedule 13G filings are common for institutional investors accumulating significant stakes in publicly traded companies or funds. Raymond James & Associates' disclosure of a 10.1% holding in the Highland Global Allocation Fund indicates a notable investment position, potentially influencing market perception or future fund activities.

Stakeholder Impact

• Shareholders of the Highland Global Allocation Fund may see increased stability or potential strategic shifts due to the significant stake held by Raymond James & Associates.
• Other investors in the market may view this disclosure as a signal of confidence in the fund, potentially influencing their own investment decisions.

Next Steps

• Raymond James & Associates will continue to hold and manage its investment in the Highland Global Allocation Fund.
• The fund may continue its investment activities as per its stated strategy.

Key Dates

Keywords

Schedule 13G, Raymond James & Associates, Highland Global Allocation Fund, Beneficial Ownership, Common Shares, Investment Holding, SEC Filing, CUSIP, Equity